SAMHSA

SAMHSA Seeks Public Comments on Maternal Mental Health

The Substance Abuse and Mental Health Services Administration (SAMHSA) is soliciting public comments on questions related to maternal mental health. This consultation aims to gather input for the Task Force on Maternal Mental Health.

SAMHSA Proposed Rule: Mandatory Drug Testing Guidelines Using Oral Fluid

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to establish mandatory guidelines for drug testing using oral fluid. This proposal aims to provide a standardized framework for federal agencies and contractors conducting such testing.

Proposed Federal Workplace Drug Testing Guidelines

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to update federal workplace drug testing guidelines. This consultation seeks public comment on the proposed changes to these guidelines.

Proposed Rule: Opioid Use Disorder Medication Regulations

The Department of Health and Human Services (HHS) has issued a Notice of Proposed Rulemaking to solicit public comment on proposed modifications to regulations concerning medications for opioid use disorder treatment. The comment period closes on February 14, 2023.

Proposed Rule to Remove Opioid Disorder Treatment Waiver Requirements

SAMHSA has issued a supplemental notice of proposed rulemaking to remove the waiver requirement for practitioners prescribing certain medications for opioid use disorder (OUD). This action follows amendments made by the Consolidated Appropriations Act, 2023, which eliminated the need for the waiver. Public comments are due by March 14, 2023.

HHS Certified Laboratories for Drug Testing

The Department of Health and Human Services (HHS) has published an updated list of certified laboratories and instrumented initial testing facilities that meet minimum standards for urine and oral fluid drug testing for federal agencies. This notice provides the current list of approved facilities.

SAMHSA Agency Information Collection Activities: Program Evaluation for Prevention Contract

The Substance Abuse and Mental Health Services Administration (SAMHSA) is requesting OMB review and public comment on a revision to its Program Evaluation for Prevention Contract (PEPC) data collection activities. This revision seeks to extend data collection through FY 2028 for the Strategic Prevention Framework for Prescription Drugs (SPF Rx) program.

HHS-Certified Laboratories for Urine/Oral Fluid Drug Testing

The Substance Abuse and Mental Health Services Administration (SAMHSA) has published the current list of HHS-certified laboratories and instrumented initial testing facilities for urine and oral fluid drug testing. This notice serves as an informational update for federal agencies and relevant parties.

SAMHSA Proposed Collection for Underage Drinking Prevention Activities

The Substance Abuse and Mental Health Services Administration (SAMHSA) has published a notice requesting public comment on a proposed collection of information related to underage drinking prevention activities. This notice initiates a 60-day comment period for interested parties.

SAMHSA Extends NSDUH Field Tests; Comment Deadline May 12

The Substance Abuse and Mental Health Services Administration (SAMHSA) has extended the field tests for the National Survey on Drug Use and Health (NSDUH). The agency is requesting public comments on this extension, with a deadline of May 12, 2026.